Proposed Data Collections Submitted for Public Comment and Recommendations, 49009-49011 [E7-16920]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 165 / Monday, August 27, 2007 / Notices
placed on an attendee list. If any person
wishes auxiliary aids (such as a sign
language interpreter) or other special
accommodations, please contact, prior
to September 5, 2007, Teri Stumpf,
Room 1209, 811 Vermont Avenue, NW.,
Washington, DC 20571, Voice: (202)
565–3502 or TDD (202) 565–3377.
Further Information: For further
information, contact Teri Stumpf, Room
1209, 811 Vermont Ave., NW.,
Washington, DC 20571, (202) 565–3502.
Howard A. Schweitzer,
General Counsel.
[FR Doc. 07–4154 Filed 8–24–07; 8:45 am]
BILLING CODE 6690–01–M
FEDERAL DEPOSIT INSURANCE
CORPORATION
Notice of Agency Meeting
rmajette on PROD1PC64 with NOTICES
Pursuant to the provisions of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b), notice is hereby given that
at 4 p.m. on Tuesday, August 21, 2007,
the Board of Directors of the Federal
Deposit Insurance Corporation met in
closed session to consider matters
relating to the Corporation’s supervisory
activities.
In calling the meeting, the Board
determined, on motion of Vice
Chairman Martin J. Gruenberg,
seconded by Mr. Scott Polakoff, acting
in the place and stead of Director John
C. Reich (Director, Office of Thrift
Supervision), concurred in by Director
Thomas J. Curry (Appointive), Director
John C. Dugan (Director, Comptroller of
the Currency), and Chairman Shelia C.
Bair, that Corporation business required
its consideration of the matters on less
than seven days’ notice to the public;
that no earlier notice of the meeting was
practicable; that the public interest did
not require consideration of the matters
in a meeting open to public observation;
and that the matters could be
considered in a closed meeting by
authority of subsections (c)(4), (c)(6),
(c)(8), and (c)(9)(A)(ii) of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b(c)(4), (c)(6), (c)(8), and
(c)(9)(A)(ii)).
The meeting was held in the Board
Room of the FDIC Building located at
550 17th Street, NW., Washington, DC.
Dated: August 22, 2007.
Federal Deposit Insurance Corporation.
Valerie J. Best,
Assistant Executive Secretary.
[FR Doc. E7–16968 Filed 8–24–07; 8:45 am]
BILLING CODE 6714–01–P
VerDate Aug<31>2005
15:56 Aug 24, 2007
Jkt 211001
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 21,
2007.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261-4528:
1. Virginia Community Capital, Inc.,
Christiansburg, Virginia, which is
currently operating as a Community
Development Financial Institution; to
become a bank holding company.
In connection with this application,
Applicant also has applied to, by
acquiring Community Capital Bank of
Virginia, Christiansburg, Virginia,
continue to engage in lending and
community development activities,
pursuant to sections 225.28(b)(1),
(b)(12)(i), and (b)(12)(ii) of Regulation Y.
B. Federal Reserve Bank of Chicago
(Burl Thornton, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
49009
1. Marshall & Ilsley Corporation,
Milwaukee, Wisconsin, and FIC
Acquisition Corporation, Indianpolis,
Indiana; to acquire 100 percent of the
voting shares of First Indiana
Corporation, and thereby indirectly
acquire voting shares of First Indiana
Bank, N.A., both of Indianapolis,
Indiana.
In connection with this application,
FIC Acquisition Corporation; has
applied to become a bank holding
company by acquiring 100 percent of
the voting shares of First Indiana
Corporation, and First Indiana Bank,
N.A., all of Indianapolis, Indiana.
Board of Governors of the Federal Reserve
System, August 22, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E7–16882 Filed 8–24–07; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–0260]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
E:\FR\FM\27AUN1.SGM
27AUN1
49010
Federal Register / Vol. 72, No. 165 / Monday, August 27, 2007 / Notices
be received within 60 days of this
notice.
Proposed Project
Health Hazard Evaluation and
Technical Assistance—Requests and
Emerging Problems—Extension (OMB
No. 0920–0260)—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In accordance with its mandates
under the Occupational Safety and
Health Act of 1970 and the Federal
Mine Safety and Health Act of 1977, the
National Institute for Occupational
Safety and Health (NIOSH) responds to
requests for health hazard evaluations
(HHE) to identify chemical, biological or
physical hazards in workplaces
throughout the United States. Each year,
NIOSH receives approximately 400 such
requests. Most HHE requests come from
the following types of companies:
Service, manufacturing companies,
health and social services,
transportation, construction,
agriculture/ mining, skilled trade and
construction.
A printed Health Hazard Evaluation
request form is available in English and
in Spanish. The form is also available
on the Internet and differs from the
printed version only in format and in
the fact that it uses an Internet address
to submit the form to NIOSH. Both the
printed and Internet versions of the
form provide the mechanism for
employees, employers, and other
authorized representatives to supply the
information required by the regulations
governing the NIOSH Health Hazard
Evaluation program (42 CFR 85.3–1). In
general, if employees are submitting the
form it must contain the signatures of
three or more current employees.
However, regulations allow a single
signature if the requestor: Is one of three
(3) or fewer employees in the process,
operation, or job of concern; or is any
officer of a labor union representing the
employees for collective bargaining
purposes. An individual management
official may request an evaluation on
behalf of the employer. The information
provided is used by NIOSH to
determine whether there is reasonable
cause to justify conducting an
investigation and provides a mechanism
to respond to the requestor.
In the case of 25% to 50% of the
health hazard evaluation requests
received, NIOSH determines an on-site
evaluation is needed. The primary
purpose of an on-site evaluation is to
help employers and employees identify
and eliminate occupational health
hazards. In most on-site evaluations
employees are interviewed to help
further define concerns, and in
approximately 50% these evaluations
(presently estimated to be about 100
facilities), questionnaires are distributed
to the employees (averaging about 40
employees per site for this last
subgroup). The interview and survey
questions are specific to each workplace
and its suspected diseases and hazards,
however, items are derived from
standard medical and epidemiologic
techniques. The request forms take an
estimated 12 minutes to complete. The
interview forms take 30 minutes to
complete.
NIOSH distributes interim and final
reports of health hazard evaluations,
excluding personal identifiers, to:
Requesters, employers, employee
representatives; the Department of Labor
(Occupational Safety and Health
Administration or Mine Safety and
Health Administration, as appropriate);
and, as needed, other state and federal
agencies.
NIOSH administers a follow-back
program to assess the effectiveness of its
health hazard evaluation program in
reducing workplace hazards. This
program entails the mailing of followback questionnaires to employer and
employee representatives at all the
workplaces where NIOSH conducted
site visits. In a small number of
instances, a follow-back on-site
evaluation may be conducted. The
initial follow-back questionnaire is
administrated immediately following
the site visits and takes about 15
minutes. Another follow-back
questionnaire is sent a year later and
requires about 15 minutes to complete.
At 24 months, a final follow-back
questionnaire regarding the completed
evaluation is sent which takes about 15
minutes to complete.
For requests where NIOSH does not
conduct an onsite evaluation, the
requester receives a follow-back
questionnaire 12 months after our
response and a second one 24 months
after our response. The first
questionnaire takes about 10 minutes to
complete and the second questionnaire
takes about 15 minutes to complete.
Because of the large number of
investigations conducted each year, the
need to respond quickly to requests for
assistance, the diverse and
unpredictable nature of these
investigations, and its follow-back
program to assess evaluation
effectiveness; NIOSH requests an
umbrella clearance for data collections
performed within the domain of its
health hazard evaluation program.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
No. of
respondents
No. of
responses/
respondent
Average burden/response
(in hours)
Total burden
(in hours)
275
107
3800
4040
760
760
760
50
50
1
1
1
1
1
1
1
1
1
12/60
12/60
15/60
30/60
15/60
15/60
15/60
10/60
15/60
55
21
950
2020
190
190
190
8
13
Total ..........................................................................................................
rmajette on PROD1PC64 with NOTICES
Employees & Representatives (request form) .................................................
Employers (request form) ................................................................................
Employees (interview) .....................................................................................
Employees (questionnaire) ..............................................................................
Employees and Employers immediately after onsite evaluation (follow-back)
Employees and Employers 12 months after onsite evaluation (follow-back)
Employees and Employers 24 months after onsite evaluation (follow-back)
Primary Requester without onsite evaluation 12 months (follow-back) ..........
Primary Requester without onsite evaluation 24 months (follow-back) ..........
........................
........................
........................
3637
VerDate Aug<31>2005
15:56 Aug 24, 2007
Jkt 211001
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
E:\FR\FM\27AUN1.SGM
27AUN1
Federal Register / Vol. 72, No. 165 / Monday, August 27, 2007 / Notices
Dated: August 20, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–16920 Filed 8–24–07; 8:45 am]
BILLING CODE 4163–18–P
Intravascular chemography
Intravascular pressure measurement
Percutaneous tracheostomy
Repair of the annulus fibrosus
Surgical gel implantation
Addenda (Procedures)
ICD–10–Procedure Classification
System (PCS) update.
Centers for Disease Control and
Prevention
FOR FURTHER INFORMATION CONTACT:
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–9–CM Coordination and
Maintenance Committee meeting.
Time and Date: 8:30 a.m.–6 p.m.,
September 27–28, 2007.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland.
Status: Open to the public.
Purpose: The ICD–9–CM Coordination
and Maintenance (C&M) Committee will
hold its final meeting of the 2007
calendar year cycle on Thursday and
Friday, September 27–28, 2007. The
C&M meeting is a public forum for the
presentation of proposed modifications
to the International Classification of
Diseases, Ninth-Revision, Clinical
Modification.
rmajette on PROD1PC64 with NOTICES
Matters To Be Discussed
Tentative agenda items include:
Androgen insensitivity
Carcinoid tumors/neuroendocrine
tumors
Decubitus ulcer expansion
Eosinophilic disorders
Fetal medicine
Functional incontinence
Heparin-induced thrombocytopenia
Isolated systolic hypertension
Keratitis (Acanthamoeba and Fusarium)
Leukemia in relapse
Necrotizing enterocolitis
Retrolental fibroplasia
Secondary diabetes
Ventilator-associated pneumonia
Wound disruption
Addenda (Diagnoses)
ICD–10–CM Update
Non-invasive positive pressure
ventilation
Laparoscopic colectomy
Laparoscopic deployed inguinal hernia
repair mesh
Oversewing of atrial appendage
Bi-ventricular replacement
Intra-aneurysm sac pressure
Direct aqueous oxygen infusion therapy
Kyphoplasty
15:56 Aug 24, 2007
Jkt 211001
and the Agency for Toxic Substances
and Disease Registry.
Diane C. Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–16903 Filed 8–24–07; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
49011
Amy Blum, Medical Systems Specialist,
Classifications and Public Health Data
Standards Staff, NCHS, 3311 Toledo
Road, Room 2402, Hyattsville, Maryland
20782, e-mail alb8@cdc.gov, telephone
301–458–4106 (diagnosis), Mady Hue,
Health Insurance Specialist, Division of
Acute Care, CMS, 7500 Security Blvd.,
Baltimore, Maryland, 21244, e-mail
marilu.hue@cms.hhs.gov, telephone
410–786–4510 (procedures).
Notice: Because of increased security
requirements CMS has instituted
stringent procedures for entrance into
the building by non-government
employees. Persons without a
government I.D. will need to show an
official form of picture I.D., (such as a
drivers license), and sign-in at the
security desk upon entering the
building.
Those who wish to attend a specific
ICD–9–CM C&M meeting in the CMS
auditorium must submit their name and
organization for addition to the meeting
visitor list. Those wishing to attend the
September 27–28, 2007 meeting must
submit their name and organization by
September 20, 2007 for inclusion on the
visitor list. This visitor list will be
maintained at the front desk of the CMS
building and used by the guards to
admit visitors to the meeting. Those
who attended previous ICD–9–CM C&M
meetings will no longer be
automatically added to the visitor list.
You must request inclusion of your
name prior to each meeting you attend.
Register to attend the meeting on-line
at: https://www.cms.hhs.gov/apps/
events/.
Notice: This is a public meeting.
However, because of fire code
requirements, should the number of
attendants meet the capacity of the
room, the meeting will be closed.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0304]
Preparation for International
Conference on Harmonization
Meetings in Yokohama, Japan; Public
Meeting; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of meeting; correction.
SUMMARY: The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register on August 13, 2007 (72 FR
45250). The document announced a
public meeting entitled ‘‘Preparation for
ICH meetings in Yokohama, Japan’’ to
provide information and receive
comments on the International
Conference on Harmonization (ICH) as
well as the upcoming meetings in
Yokohama, Japan. The topics to be
discussed are the topics for discussion
at the forthcoming ICH Steering
Committee Meeting. The purpose of the
meeting is to solicit public input prior
to the next Steering Committee and
Expert Working Groups meetings in
Yokohama, Japan, October 27 through
November 1, 2007, at which discussion
of the topics underway and the future of
ICH will continue.
FOR FURTHER INFORMATION CONTACT: For
information regarding this notice and
the original notice: Tammie Bell, Office
of the Commissioner, Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, e-mail:
Tammie.Bell2@fda.hhs.gov, FAX: 301–
827–0003.
SUPPLEMENTARY INFORMATION: In FR Doc.
E7–15803, appearing on page 45250 in
the Federal Register of Monday, August
13, 2007, the following correction is
made:
1. On page 45250, in the third
column, the second full paragraph is
corrected to read ‘‘Interested persons
may present data, information, or views
orally or in writing, on issues pending
at the public meeting. Oral
presentations from the public will be
scheduled between approximately 2:30
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 72, Number 165 (Monday, August 27, 2007)]
[Notices]
[Pages 49009-49011]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-16920]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-07-0260]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should
[[Page 49010]]
be received within 60 days of this notice.
Proposed Project
Health Hazard Evaluation and Technical Assistance--Requests and
Emerging Problems--Extension (OMB No. 0920-0260)--National Institute
for Occupational Safety and Health (NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In accordance with its mandates under the Occupational Safety and
Health Act of 1970 and the Federal Mine Safety and Health Act of 1977,
the National Institute for Occupational Safety and Health (NIOSH)
responds to requests for health hazard evaluations (HHE) to identify
chemical, biological or physical hazards in workplaces throughout the
United States. Each year, NIOSH receives approximately 400 such
requests. Most HHE requests come from the following types of companies:
Service, manufacturing companies, health and social services,
transportation, construction, agriculture/ mining, skilled trade and
construction.
A printed Health Hazard Evaluation request form is available in
English and in Spanish. The form is also available on the Internet and
differs from the printed version only in format and in the fact that it
uses an Internet address to submit the form to NIOSH. Both the printed
and Internet versions of the form provide the mechanism for employees,
employers, and other authorized representatives to supply the
information required by the regulations governing the NIOSH Health
Hazard Evaluation program (42 CFR 85.3-1). In general, if employees are
submitting the form it must contain the signatures of three or more
current employees. However, regulations allow a single signature if the
requestor: Is one of three (3) or fewer employees in the process,
operation, or job of concern; or is any officer of a labor union
representing the employees for collective bargaining purposes. An
individual management official may request an evaluation on behalf of
the employer. The information provided is used by NIOSH to determine
whether there is reasonable cause to justify conducting an
investigation and provides a mechanism to respond to the requestor.
In the case of 25% to 50% of the health hazard evaluation requests
received, NIOSH determines an on-site evaluation is needed. The primary
purpose of an on-site evaluation is to help employers and employees
identify and eliminate occupational health hazards. In most on-site
evaluations employees are interviewed to help further define concerns,
and in approximately 50% these evaluations (presently estimated to be
about 100 facilities), questionnaires are distributed to the employees
(averaging about 40 employees per site for this last subgroup). The
interview and survey questions are specific to each workplace and its
suspected diseases and hazards, however, items are derived from
standard medical and epidemiologic techniques. The request forms take
an estimated 12 minutes to complete. The interview forms take 30
minutes to complete.
NIOSH distributes interim and final reports of health hazard
evaluations, excluding personal identifiers, to: Requesters, employers,
employee representatives; the Department of Labor (Occupational Safety
and Health Administration or Mine Safety and Health Administration, as
appropriate); and, as needed, other state and federal agencies.
NIOSH administers a follow-back program to assess the effectiveness
of its health hazard evaluation program in reducing workplace hazards.
This program entails the mailing of follow-back questionnaires to
employer and employee representatives at all the workplaces where NIOSH
conducted site visits. In a small number of instances, a follow-back
on-site evaluation may be conducted. The initial follow-back
questionnaire is administrated immediately following the site visits
and takes about 15 minutes. Another follow-back questionnaire is sent a
year later and requires about 15 minutes to complete. At 24 months, a
final follow-back questionnaire regarding the completed evaluation is
sent which takes about 15 minutes to complete.
For requests where NIOSH does not conduct an onsite evaluation, the
requester receives a follow-back questionnaire 12 months after our
response and a second one 24 months after our response. The first
questionnaire takes about 10 minutes to complete and the second
questionnaire takes about 15 minutes to complete.
Because of the large number of investigations conducted each year,
the need to respond quickly to requests for assistance, the diverse and
unpredictable nature of these investigations, and its follow-back
program to assess evaluation effectiveness; NIOSH requests an umbrella
clearance for data collections performed within the domain of its
health hazard evaluation program. There is no cost to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
No. of Average burden/
Type of respondent No. of responses/ response (in Total burden
respondents respondent hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Employees & Representatives (request form)...... 275 1 12/60 55
Employers (request form)........................ 107 1 12/60 21
Employees (interview)........................... 3800 1 15/60 950
Employees (questionnaire)....................... 4040 1 30/60 2020
Employees and Employers immediately after onsite 760 1 15/60 190
evaluation (follow-back).......................
Employees and Employers 12 months after onsite 760 1 15/60 190
evaluation (follow-back).......................
Employees and Employers 24 months after onsite 760 1 15/60 190
evaluation (follow-back).......................
Primary Requester without onsite evaluation 12 50 1 10/60 8
months (follow-back)...........................
Primary Requester without onsite evaluation 24 50 1 15/60 13
months (follow-back)...........................
---------------------------------------------------------------
Total....................................... .............. .............. .............. 3637
----------------------------------------------------------------------------------------------------------------
[[Page 49011]]
Dated: August 20, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-16920 Filed 8-24-07; 8:45 am]
BILLING CODE 4163-18-P
